MI
MGIC INVESTMENT CORP (MTG)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered solid profitability: net income $192.5M ($0.81 GAAP EPS) and adjusted EPS $0.82; EPS benefited from $54M favorable prior-year reserve development as cure rates continued to outperform assumptions .
- Topline was stable with total revenues of $304.2M, slightly below S&P Global revenue consensus ($306.3M), but EPS beat consensus ($0.72) by ~$0.10 on reserve releases and disciplined expenses; net realized investment losses reduced GAAP EPS by ~$0.01 *.
- Credit remains benign: loss ratio improved to (1.2)% (vs 3.9% in Q1 and 3.6% in Q4), primary delinquency rate declined to 2.21% from 2.30% in Q1; NIW accelerated to $16.4B, supporting Insurance in Force at $297.0B .
- Capital return is a key catalyst: 7.1M shares repurchased for $180.7M in Q2; dividend raised 15% to $0.15; an additional $750M buyback authorization was approved in April; holding company liquidity ended Q2 at ~$1.05B .
What Went Well and What Went Wrong
-
What Went Well
- Strong EPS beat on favorable reserve development and stable core drivers. “Cure rates on recent delinquency notices continue to exceed our expectations,” driving $54M favorable loss development in the quarter .
- Credit and cost discipline: loss ratio improved to (1.2)% and underwriting expense ratio fell sequentially to 21.9% (22.5% in Q1) .
- Capital return and balance sheet strength: repurchased $181M in Q2, boosted dividend to $0.15, ended Q2 with ~$1.0B holdco liquidity; management reiterated elevated payout ratios can continue if growth remains constrained and credit performance holds .
-
What Went Wrong
- Slight revenue shortfall vs consensus ($304.2M vs $306.3M), with modest net realized investment losses (-$1.4M) weighing on total revenues *.
- Persistency remains high (84.7%), limiting IIF churn and potentially pressuring long-term portfolio yield as older higher-rate books run off and new pricing remains competitive .
- Management flagged seasonality and vintage aging (2021–2022 books) likely to push delinquencies higher in H2, even if levels remain low by historical standards .
Financial Results
Overall results vs prior quarters and S&P Global consensus
Values marked with * are from S&P Global.
Operating KPIs
Non-GAAP adjustments (context)
- Net realized investment losses added ~$0.01 to adjusted EPS reconciliation in Q2; adjusted EPS was $0.82 vs GAAP $0.81 .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “In the second quarter, we recorded net income of $193 million and an annualized return on equity of 15%...we wrote $16 billion of new insurance. Insurance in force...$297 billion.” — CEO Tim Mattke .
- “Cure rates on recent delinquency notices continue to exceed our expectations...we adjusted our ultimate loss expectations accordingly,” resulting in $54M favorable loss reserve development — CFO Nathan Colson .
- “We continued to allocate excess capital to share repurchases...and paid a quarterly common stock dividend...we repurchased an additional 2.6 million shares [through July 25].” — CEO Tim Mattke .
- “We further bolstered our reinsurance program in the second quarter with two excess of loss agreements...These complement the 40% quota share arrangements” — CFO Nathan Colson .
Q&A Highlights
- Capital return framework: Management targets strong operating and holdco capital, and with constrained growth, expects elevated payout ratios to continue; operating-company dividends sized by ongoing results and contingency reserve constraints; preference is steady, not one-off, capital return .
- Home prices and pricing dynamics: Expect national HPI to be roughly flat with regional divergence; risk-based pricing enables rapid, granular adjustments to pockets of risk; slowing HPA is long-term constructive for MI .
- Operating expenses: FY OpEx guidance ($195–$205M) includes Q2’s $4M pension lump-sum accounting charge, with smaller charges anticipated later in the year; visibility provided via footnotes .
Estimates Context
- Q2 2025 EPS: Actual $0.82 vs S&P Global consensus $0.7175 — beat of ~$0.10; Revenue: Actual $304.2M vs S&P Global consensus $306.3M — slight miss *.
- Estimate breadth: 4 estimates for EPS and 4 for revenue [GetEstimates]*.
- Implication: The EPS beat is primarily from favorable reserve development and cost control; revenue variance was modest and partly impacted by net investment losses .
Values marked with * are from S&P Global.
Key Takeaways for Investors
- EPS beat driven by favorable credit development and lean expenses; reserve releases underscore benign credit in recent vintages and strong cure performance .
- Core revenue drivers remained steady (NPE + IIF + yields), while total revenue faced a modest investment loss headwind; outlook for in-force premium yield is “relatively flat” for 2025 .
- Loss ratio improvement to (1.2)% and a lower delinquency rate point to durable credit quality heading into H2, though seasonal uptick and vintage aging are expected .
- Capital return is the near-term narrative: buybacks, a 15% dividend hike, and ~$1.0B holdco liquidity support continued elevated payouts if growth opportunities remain limited .
- Reinsurance expansion (new XOLs) and PMIERs excess ($2.4B) provide capital flexibility and loss volatility protection, supporting sustained shareholder returns through the cycle .
- Watch items: H2 delinquency seasonality, regional HPI divergence, investment income trajectory amid rate moves, and any PMIERs/GSE policy changes impacting capital credit or pricing .
S&P Global disclaimer: Consensus estimates values denoted with * were retrieved from S&P Global.